This inventor holds 1 USPTO granted patent. Top assignees: Icahn School of Medicine at Mount Sinai, University of Ghent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Jana De Vrieze: Innovator in Immunology
Introduction
Jana De Vrieze is a notable inventor based in Lievegem, Belgium. She has made significant contributions to the field of immunology through her innovative research and development of new compounds. Her work focuses on enhancing immune responses, which is crucial for advancing medical treatments and vaccines.
Latest Patents
Jana holds a patent for the invention titled "IMDQ-PEG-CHOL adjuvant and uses thereof." This patent describes lipidated imidazoquinoline compounds and their compositions. These compounds serve as adjuvants to enhance the immune response elicited by specific antigens. The methods outlined in her patent involve administering these compounds in combination with immunogenic compositions to improve the immune response in subjects.
Career Highlights
Throughout her career, Jana has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and the University of Ghent. Her research has been instrumental in developing new strategies for immunotherapy and vaccine enhancement.
Collaborations
Jana has collaborated with notable colleagues such as Michael Schotsaert and Angela Choi. These partnerships have furthered her research and contributed to the advancement of immunological studies.
Conclusion
Jana De Vrieze is a pioneering inventor whose work in immunology has the potential to significantly impact medical science. Her innovative approaches to enhancing immune responses are paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile